Supplementary Figure S2 from Glypican-3–Targeted PET Imaging for Precise Diagnosis of Hepatocellular Carcinoma: From Bench to Bedside

Zhaoguo Lin; Mengting Li; Zhidi Pan; Wenzhu Hu; Yuan Feng; Xiao Zhang; Haiyang Yin; Shusheng Wang; Zhangyi Song; Xiaoying Lv; Xiangming Song; Danzha Zheng; Weiwei Ruan; Yongkang Gai; Ming Xia Yang; Dawei Jiang; Xiong Cai; Jianwei Zhu; Xiaoli Lan

doi:10.1158/1078-0432.31248661

Supplementary Figure S2 from Glypican-3–Targeted PET Imaging for Precise Diagnosis of Hepatocellular Carcinoma: From Bench to Bedside

2026 Open access

Read full text

Authors: Zhaoguo Lin, Mengting Li, Zhidi Pan, Wenzhu Hu, Yuan Feng, Xiao Zhang, Haiyang Yin, Shusheng Wang, Zhangyi Song, Xiaoying Lv, Xiangming Song, Danzha Zheng

+7 more

Weiwei Ruan, Yongkang Gai, Ming Xia Yang, Dawei Jiang, Xiong Cai, Jianwei Zhu, Xiaoli Lan

DOI: 10.1158/1078-0432.31248661

Cited by: 0

Abstract

Supplementary Figure S2. Sample purity determination using size exclusion-high-performance liquid chromatography. The purity of anti-GPC3 scFv (XH-06) was 100%.

Fields of Study & Subjects

Radiopharmaceutical Chemistry and Applications Hepatocellular Carcinoma Treatment and Prognosis Medical Imaging Techniques and Applications

Publication details

Publication date: 4 February 2026